Compliance
The 2026 Compliance Checklist for Peptide Clinics
Published March 10, 2026 · 9 min read
Most peptide programs fail audit not because of clinical decisions, but because of operational sloppiness. This is the checklist.
Sourcing
Every product comes from a licensed 503A or 503B pharmacy with a current state and FDA registration. No research-chemical suppliers, ever.
- State board license on file
- FDA 503B registration where applicable
- COA on every batch
Prescribing
A licensed prescriber in every state you treat. Documented chart, intake, and consent for every patient.
Labeling & storage
Patient-specific labels for 503A. Temperature-controlled storage with logs. Lot numbers and expiration tracked.
Telehealth
Confirm your prescribers are licensed in the patient's state at the moment of the visit, not just at signup.
Launch your white-label program
Apply to Direct Peptide Sales, most practices onboard inside 30 days.
Apply now →